100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
BCMAS Exam| 283 Questions and Answers 100% Correct $12.99   Add to cart

Exam (elaborations)

BCMAS Exam| 283 Questions and Answers 100% Correct

 16 views  0 purchase
  • Course
  • BCMAS
  • Institution
  • BCMAS

BCMAS Exam| 283 Questions and Answers 100% CorrectBCMAS Exam| 283 Questions and Answers 100% CorrectBCMAS Exam| 283 Questions and Answers 100% CorrectBCMAS Exam| 283 Questions and Answers 100% Correct Most commonly used study design: - ANSWER-parallel Under what conditions can a pharma company ...

[Show more]

Preview 3 out of 26  pages

  • July 12, 2024
  • 26
  • 2023/2024
  • Exam (elaborations)
  • Questions & answers
  • BCMAS
  • BCMAS
avatar-seller
NursingTutor1
BCMAS Exam| 283 Questions and Answers 100% Correct
Most commonly used study design: - ANSWER-parallel
Under what conditions can a pharma company provide financial support for conferences
and CME? - ANSWER-The grants/contributions are separate from other company funds
The company has had no control over the selection of content, faculty, or venue
Not required by ADR reporting: - ANSWER-careful selection of clinical trial participants
Required:
-recognition of events
-safety signals are identified against a background of events
-accurate reporting
Individual board members are known as: - ANSWER-advisors
in vitro diagnostic test - example - ANSWER-microbiology culture
When first working on a publication, what should authors do to identify their rights, roles,
and responsibilities? - ANSWER-Document the agreement
in vitro versus in vivo - ANSWER-in vitro describes something "in glass" such as a test tube or petri dish
in vivo is "within a living organism"
Fundamental requirement for ongoing risk evaluations of REMS: - ANSWER-timely data
collection
T/F: Medical writers should avoid addressing the public's questions to prevent the spread of health misinformation. - ANSWER-False
What would cause the FDA to require post-marketing studies or clinical trials at the time
of approval or afterwards for a new product? - ANSWER-If the FDA becomes aware of new safety information from SADR reporting.
The process of internal cooperation, coordination, and common standards across the global pharmaceutical industry is referred to as: - ANSWER-Harmonization Best practice and ethical standards for reporting research published in medical journals - ANSWER-ICMJE
T/F: Elements to Assure Safe Use (ETASU) are required medical interventions taken by
HCPs prior to using the drug. - ANSWER-True
Combination product applicant(s) - ANSWER-The company that holds the application for the combination product as a whole
T/F: Severe birth defects is not an FDA mandated REMS. - ANSWER-False
Export challenge of a medical device company: - ANSWER-Violation of intellectual property rights
Purposes of IIS - ANSWER-develop and support new indication
enhance pt benefits/health outcomes
improve available product safety and NOT a purpose = support pt community
Goals of pharmacogenomics - ANSWER-Individualize therapies based on genetic differences
Predict individual responses to a drug to decrease adverse drug reactions
Improve the overall efficacy and safety of drugs
NOT a goal = decrease medication adherence
FDA clearance for medical devices - ANSWER-May be given for devices with substantial equivalence to a known predicate device
Allows the device to be marketed and sold once a Pre-Market Notification has been submitted
May be issued if the device existed in the market prior to 1976
EBM databases - ANSWER-DynaMed
Cochrane Library
T/F: Presentation skills are not essential for maintaining a position with MA. - ANSWER-
False
5-step process to respond to a medical information question - ANSWER-1) Determine who the audience is
2) Understand what the primary question is
3) Develop an appropriate research strategy
4) Choose the best source 5) Assess the information source and answer the question
T/f: SRDs are prepared only for HCPs in response to questions about product(s). - ANSWER-False
Who is required to submit a periodic safety update report? - ANSWER-Marketing authorization holders (MAHs) according to the data points outlined in the EURD list.
T/F: Surveys are classified as cross-sectional studies. - ANSWER-True
Medical Device User Fees Amendment of 2012 - ANSWER-Allows the FDA to collect user fees for pre-market approvals to improve the overall review process
T/F: An abbreviated new drug application (ANDA) is submitted to the FDA for generic drugs. - ANSWER-True
The risk associated with this type of drug may not be well understood. - ANSWER-New drug substance
Amber is an MSL and receives a question from a physician about a medication indication that is not FDA approved. Which of the following is true? - ANSWER-This is an unsolicited request.
This information is off-label.
A Pharma company is looking to begin the development of a new drug. Why would the company consult an advisory board? - ANSWER-To provide their opinion on the research and development of the drug
T/F: Under the second-tier regulations, in 21 CFR Part 56 (Institutional Review Board (IRB)) subpart B, there needs to be a minimum of 2 members in the IRB. - ANSWER-
False
Compare a drug with other currently available medications in the same class
Detect other uses of the drugs
Approximately how many slides should a 15 minute presentation include? - ANSWER-
7-8
Dr. Simpson, a neurologist, occasionally participates on an advisory board for Lightning Pharmaceuticals. Dr. Simpson has also just become a member of a national committee that makes recommendations for clinical guidelines and formulary decisions. Is Dr. Simpson required to disclose her relationship with Lightning Pharmaceuticals to the national committee she is a member of? - ANSWER-Yes, it would be unethical and potentially a conflict of interest if she does not disclose the relationship.

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller NursingTutor1. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $12.99. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

77254 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
$12.99
  • (0)
  Add to cart